Safety and Effectiveness of Rosiglitazone in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease ranging in severity from steatosis to cirrhosis. Type 2 diabetes mellitus is a cause of primary NAFLD. Thiazolidinediones have been shown to enhance insulin sensitivity, improve glycemic control in type 2 diabetes patients an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the Formosan Medical Association 2006-09, Vol.105 (9), p.743-752
Hauptverfasser:	Wang, Chao-Hung, Leung, Ching-Hsiang, Liu, Sung-Chen, Chung, Cheng-Ho
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis of Variance Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Fatty Liver - drug therapy Fatty Liver - etiology Female Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Male Middle Aged Rosiglitazone Thiazolidinediones - adverse effects Thiazolidinediones - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!